Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP and conditioned medium ovarian injection in infertile women with poor ovarian response
IRCT20240815062771N2Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Feb 2025
- Countries
- 1
01
Overview
Phase 2, open-label trial of platelet-rich plasma in poor ovarian response (POR) and female infertility (3 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Clinical pregnancy, Chemical pregnancy and 1 more. Started Feb 2025; status: completed.
02
Drugs
platelet-rich plasma
03
Conditions
poor ovarian response (POR)female infertility
Beyond the preview
Go deeper on IRCT20240815062771N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240815062771N2.